A detailed history of Cahaba Wealth Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Cahaba Wealth Management, Inc. holds 3,267 shares of ABBV stock, worth $556,533. This represents 0.05% of its overall portfolio holdings.

Number of Shares
3,267
Previous 3,258 0.28%
Holding current value
$556,533
Previous $558,000 15.59%
% of portfolio
0.05%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$163.84 - $199.33 $1,474 - $1,793
9 Added 0.28%
3,267 $645,000
Q2 2024

Aug 05, 2024

BUY
$154.79 - $180.76 $1,547 - $1,807
10 Added 0.31%
3,258 $558,000
Q1 2024

Apr 22, 2024

SELL
$159.82 - $182.1 $639 - $728
-4 Reduced 0.12%
3,248 $591,000
Q4 2023

Jan 23, 2024

SELL
$137.6 - $154.97 $109,529 - $123,356
-796 Reduced 19.66%
3,252 $503,000
Q3 2023

Oct 18, 2023

SELL
$133.59 - $154.65 $24,446 - $28,300
-183 Reduced 4.33%
4,048 $603,000
Q2 2023

Jul 26, 2023

BUY
$132.51 - $164.9 $230,037 - $286,266
1,736 Added 69.58%
4,231 $570,000
Q1 2023

May 04, 2023

BUY
$144.61 - $166.54 $1,012 - $1,165
7 Added 0.28%
2,495 $397,000
Q4 2022

Jan 30, 2023

SELL
$138.31 - $165.87 $6,362 - $7,630
-46 Reduced 1.82%
2,488 $402,000
Q3 2022

Oct 18, 2022

SELL
$134.21 - $153.93 $402 - $461
-3 Reduced 0.12%
2,534 $340,000
Q2 2022

Jul 19, 2022

BUY
$137.62 - $174.96 $1,376 - $1,749
10 Added 0.4%
2,537 $388,000
Q1 2022

May 05, 2022

BUY
$131.98 - $163.75 $99,908 - $123,958
757 Added 42.77%
2,527 $371,000
Q4 2021

Feb 01, 2022

BUY
$107.43 - $135.93 $190,151 - $240,596
1,770 New
1,770 $240,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cahaba Wealth Management, Inc. Portfolio

Follow Cahaba Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cahaba Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cahaba Wealth Management, Inc. with notifications on news.